These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32506510)

  • 1. MYC expression has limited utility in the distinction of undifferentiated radiation-associated sarcomas from sporadic sarcomas and sarcomatoid carcinoma.
    Mito JK; Qian X; Jo VY; Doyle LA
    Histopathology; 2020 Oct; 77(4):667-672. PubMed ID: 32506510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis.
    Hrycaj SM; Szczepanski JM; Zhao L; Siddiqui J; Thomas DG; Lucas DR; Patel RM; Harms PW; Bresler SC; Chan MP
    Histopathology; 2022 Dec; 81(6):818-825. PubMed ID: 36102613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.
    Lucas DR; Pass HI; Madan SK; Adsay NV; Wali A; Tabaczka P; Lonardo F
    Histopathology; 2003 Mar; 42(3):270-9. PubMed ID: 12605647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-associated sarcomas other than malignant peripheral nerve sheath tumours demonstrate loss of histone H3K27 trimethylation
    Panse G; Mito JK; Ingram DR; Wani K; Khan S; Lazar AJ; Doyle LA; Wang WL
    Histopathology; 2021 Jan; 78(2):321-326. PubMed ID: 32735735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC immunohistochemistry in angiosarcoma and atypical vascular lesions: practical considerations based on a single institutional experience.
    Udager AM; Ishikawa MK; Lucas DR; McHugh JB; Patel RM
    Pathology; 2016 Dec; 48(7):697-704. PubMed ID: 27780597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
    Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
    Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of MYC gene amplification is a common feature of radiation-induced sarcomas. Further results from EORTC STBSG TL 01/01.
    Käcker C; Marx A; Mössinger K; Svehla F; Schneider U; Hogendoorn PC; Nielsen OS; Küffer S; Sauer C; Fisher C; Hallermann C; Hartmann JT; Blay JY; Mechtersheimer G; Hohenberger P; Ströbel P
    Genes Chromosomes Cancer; 2013 Jan; 52(1):93-8. PubMed ID: 23012233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms.
    Attanoos RL; Dojcinov SD; Webb R; Gibbs AR
    Histopathology; 2000 Sep; 37(3):224-31. PubMed ID: 10971698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10 immunoreactivity in sarcomatoid carcinomas: comparison with true sarcomas.
    Vennapusa B; Fischer EG; Wick MR; Cerilli LA
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):408-12. PubMed ID: 21908981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INSM1 Expression in Angiosarcoma.
    Warmke LM; Tinkham EG; Ingram DR; Lazar AJ; Panse G; Wang WL
    Am J Clin Pathol; 2021 Mar; 155(4):575-580. PubMed ID: 33210141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Pathologic Characterization of 94 Radiation-Associated Sarcomas: Our Institutional Experience.
    Kao EY; McEwen AE; Aden JK; Schaub SK; Ricciotti RW; Mantilla JG
    Int J Surg Pathol; 2023 Aug; 31(5):532-547. PubMed ID: 35695212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibin is more specific than calretinin as an immunohistochemical marker for differentiating sarcomatoid granulosa cell tumour of the ovary from other spindle cell neoplasms.
    Shah VI; Freites ON; Maxwell P; McCluggage WG
    J Clin Pathol; 2003 Mar; 56(3):221-4. PubMed ID: 12610103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target.
    Komdeur R; Hoekstra HJ; Molenaar WM; Van Den Berg E; Zwart N; Pras E; Plaza-Menacho I; Hofstra RM; Van Der Graaf WT
    Clin Cancer Res; 2003 Aug; 9(8):2926-32. PubMed ID: 12912938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1.
    Lewis JS; Ritter JH; El-Mofty S
    Mod Pathol; 2005 Nov; 18(11):1471-81. PubMed ID: 15976812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of SATB2 in primary cutaneous sarcomatoid neoplasms: a potential diagnostic pitfall.
    Szczepanski JM; Siddiqui J; Patel RM; Harms PW; Hrycaj SM; Chan MP
    Pathology; 2023 Apr; 55(3):350-354. PubMed ID: 36732203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
    Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
    J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung.
    Berg KB; Churg A
    Am J Surg Pathol; 2017 Sep; 41(9):1221-1225. PubMed ID: 28614203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERG expression in epithelioid sarcoma: a diagnostic pitfall.
    Miettinen M; Wang Z; Sarlomo-Rikala M; Abdullaev Z; Pack SD; Fetsch JF
    Am J Surg Pathol; 2013 Oct; 37(10):1580-5. PubMed ID: 23774169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast.
    Kuba MG; Xu B; D'Angelo SP; Rosenbaum E; Plitas G; Ross DS; Brogi E; Antonescu CR
    Histopathology; 2021 Nov; 79(5):836-846. PubMed ID: 34165212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
    Ito J; Asano N; Kawai A; Yoshida A
    Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.